Impairment of Financial Assets: Assessment and Recognition of Impairment Losses on
Investments
Introduction
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
Impairment testing requirements introduced by the Financial Accounting Standards Board
have significantly changed the way companies identify and account for impairment losses in
their investment portfolios. By requiring recognition of impairment losses when an unrealized
loss is deemed to be other-than-temporary, these rules aim to enhance the transparency and
reliability of reported earnings and balance sheet values. However, impairment assessment
demands careful analysis and judgment to support technical compliance with standards.
This paper provides an overview of key concepts relating to impairment of financial assets
under US GAAP. It discusses indicators of potential impairment along with quantitative and
qualitative factors in determining when losses are deemed other-than-temporary. Methods for
calculating impairment charges are also explored. Appropriate identification, measurement
and disclosure of asset valuation issues ensures investors receive decision-useful information
regarding the financial health and performance of the reporting entity.
Scope and Technical Criteria
The scope of financial assets subject to impairment assessment includes investments such as:
- Debt securities like bonds held as available-for-sale or held-to-maturity
- Equity securities with a readily determinable fair value
- Cost-method equity investments lacking a readily determinable fair value
- Notes and loans receivable carried at amortized cost
To determine if and when impairment exists, technical criteria use thresholds related to:
- Fair value significantly below amortized cost for debt
- Fair value significantly below cost for equity shares or cost-method investments
- Adverse conditions raising doubts as to ability/intent to hold
A fair value significantly below historical cost establishes an objective preliminary
impairment indicator. But additional analysis considering facts and circumstances is also
required.
Factors in Assessing Impairment
Determining whether a decline in value represents an other-than-temporary impairment
demands a rigorous analysis weighing both quantitative and qualitative factors. Relevant
criteria include:
Quantitative:
- Magnitude and duration of fair value decline below cost
- Financial condition and near-term prospects of issuer
- Ability and intent to hold until anticipated recovery
Qualitative:
- Industry outlook and volatility
- Geopolitical and macroeconomic issues
- Violations of debt covenants or bankruptcy filings
- Deterioration in credit ratings
- Changes reducing future cash flows
- Evidence of fraud or mismanagement
No single factor is determinative. Significance and interaction of indicators requires judgment
considering issuer-specific evidence as well as market-based perspectives. Both asset-specific
evidence and general economic conditions influence assessments.
Calculating Impairment Charges
If an other-than-temporary impairment exists, standards mandate recognizing a charge in the
income statement:
Equity Securities
- Record full difference between cost and fair value as impairment charge. Write asset down
to fair value.
Debt Securities
- Calculate credit and non-credit related components of decline in value.
- Credit losses reduce amortized cost basis and non-credit portion reduces other
comprehensive income.
Cost-Method Investments
- Estimate impairment based on comparison of investment carrying amount to discounted
present value of expected future cash flows.
Loans and Notes Receivable
- Calculate loss based on present value of expected future cash flows discounted at original
effective interest rate.
Establishing charges requires reliable fair value estimates and cash flow projections using
reasonable forecasts to support accuracy and consistency in measurement.
Disclosure Requirements
To ensure transparency around impairment policies and effects, several qualitative and
quantitative disclosures are mandated:
- Accounting policies for impairment identification and calculation methods
- Details of factors considered in assessing impairment
- Carrying values pre- and post-impairment charge by asset class
- Aggregate impairment amounts recognized in the period
- Credit losses on debt securities held at reporting date
Disclosures provide insight into the impacts and risks posed by potentially impaired
investments. Enhanced transparency improves understanding of reported results and financial
condition.
Conclusion
Proper identification and measurement of impairment losses for financial assets demand
diligence and judgment to comply with technical standards while faithfully reflecting
underlying economic realities. Despite challenges in assessment and valuation, adherence to
principles-based guidance bolstered by robust qualitative and quantitative disclosures
enhances integrity and usefulness of reported information for external stakeholders.
Continuous monitoring serves to proactively identify and address issues impacting the
financial statements on a timely basis.
